During development, newly born neurons migrate away from their initial birth sites to their final positions in the mature brain. The neurotrophin BDNF has been shown to regulate the migration of granule cells in the cerebellum. The cellular mechanisms that mediate this chemotactic response have not been resolved. In this issue of Neuron, Zhou et al. show that vesicle trafficking is critical for allowing neurons to respond to a gradient of BDNF.
A key step in development of the mammalian CNS is the migration of newly born, immature neurons from proliferative, neurogenic regions to their final positions in the mature brain. One place where this migration has been well characterized is the cerebellum. During development, the cerebellar granule cells proliferate as neuroblasts in the external granule layer (EGL), exit the cell cycle, polarize, and then migrate along Bergmann glial cells to the internal granule layer (IGL), where they undergo morphological differentiation. How granule cells accomplish this journey is enigmatic; they must orient correctly as they prepare to leave the EGL, become motile, and then move in a directional manner. The molecular mechanism by which these events occur is the subject of the study of Zhou et al. (2007) in this issue of Neuron.
Brain-derived neurotrophic factor (BDNF) is one of a number of growth factors that are known to regulate granule cell migration. The importance of BDNF in this response was first documented by Jones et al. (1994) , who noted that the EGL persisted in bdnf À/À mice. The Segal lab then showed that the EGL was thicker in these mice and surmised that this might be due to a lack of migration of granule cells from the EGL to IGL (Schwartz et al., 1997 To address these questions, Zhou et al. (2007) established a migration assay, consisting of cultured cells exposed to a gradient of BDNF diffusing from an agarose plug, where they could readily probe both cellular and molecular aspects of directed granule cell migration. While BDNF increased migration regardless of whether the cells were exposed to a uniform or directional gradient, the cells vastly preferred to migrate toward BDNF. This chemotactic effect of BDNF required the TrkB-BDNF receptor and not the p75 neurotrophin receptor, consistent with the known role of TrkB in neuronal migration (Medina et al., 2004) . Since BDNF expression is nonuniformly distributed in the cerebellum, with higher levels in the IGL than EGL (Borghesani et al., 2002) , these findings were consistent with the idea that BDNF functioned in an exogenous gradient to promote motogenesis and directed migration. If this was the case, then the bdnf À/À granule cells should be able to migrate toward a gradient of BDNF. The surprise was that while these cells were fully capable of nondirectional migration in response to BDNF, they could not move directionally toward a BDNF gradient. Moreover, when BDNF was knocked down in individual granule cells in slice cultures using RNAi, this was sufficient to stop their migration. Thus, there was more to directed movement than migration on a static BDNF gradient, and autocrine BDNF must be somehow playing a role in either initiating or maintaining the directional response.
A clue as to how BDNF promoted this directional chemotaxis came from an analysis of its effects on granule cell polarity in culture. Zhou et al. (2007) observed in response to a BDNF gradient that activated TrkB was clustered and localized toward the leading process facing the gradient. Activated TrkB also clustered near the plasma membrane in response to uniform BDNF, but these localized clusters had no directionality. In both cases, much of this activated TrkB was localized to endosomes, and not to the plasma membrane. Importantly, in the cerebellum TrkB was also polarized toward the IGL and colocalized with endosomes, while in bdnf À/À mice, (Sadakata et al., 2007) , and ARFGEF2, required for vesicle transport from the Golgi to the plasma membrane (Sheen et al., 2004) . There remains, however, the unanswered question as to why bdnf À/À cells fail to migrate toward BDNF in culture, regardless of the BDNF concentration gradient. This finding suggests that amplifying the BDNF gradient, at least in culture, cannot overcome the lack of endogenously produced BDNF; bdnf À/À cells remain ''blind'' to the exogenous BDNF gradient. Thus autocrine BDNF is required to make the cells competent to respond to an exogenous BDNF gradient. How could this happen? The requirement for autocrine BDNF indicates that this factor must function to establish and maintain the polarity of the activated TrkB endosomes. One mechanism that might account for this result is that vesicles incorporating endogenous BDNF contain signals for trafficking to the leading process, and BDNF ushers TrkB to this site. The signal for establishment and maintenance of directional migration is therefore asymmetrical accumulation of endogenous BDNF itself, rather than that of polarized endosomes per se. One way to test this would be to redirect BDNF away from the regulated secretory vesicle system that is presumably targeted to the leading process to constitutive secretory vesicles. This could be accomplished by overexpressing the neurotrophin NT4, which heterodimerizes with newly synthesized BDNF and redirects it to constitutive secretory vesicles (Hibbert et al., 2003) . It would also be interesting to see if NT4, a TrkB ligand that is secreted in a constitutive rather than regulated fashion, could substitute for BDNF in the bdnf À/À granule cells.
Having established a model for directional migration of granule cells, Zhou et al. (2007) next determined the mechanism by which this occurs. The first signaling pathway identified was PI3 kinase; pharmacological inhibition of PI3 kinase activity blocked BDNF-mediated initiation and directional migration, but not basal migration. BDNF also induced the activity of a second pathway regulated by the small GTP-binding protein Rac1, and suppression of Rac1 activity prevented BDNF-mediated directional migration. Both of these pathways function in chemotaxis and the modification of the actin cytoskeleton (Fukata et al., 2003) and so are reasonable candidates for modulators of directional migration. As a previous study showed that TrkB regulates Rac1 activity and cell morphology by phosphorylating and activating the guanine nucleotide exchange factor Tiam 1 (Miyamoto et al., 2006) , Zhou et al. (2007) asked whether Tiam1 is a crucial signaling protein for BDNF-induced chemotaxis. Inhibition of Tiam1 expression suppressed both BDNF-induced Rac1 activity and directional migration in both cultures and cerebellar slices. Tiam1, as well as PIP3, a product of PI3 kinase activity, colocalized with TrkB and endosomes in the leading process, and this localization of Tiam1 was reduced in granule cells in bdnf À/À mice. Therefore, both PI3 kinase and Tiam1/Rac1 signaling pathways appear to be critical determinants of BDNF-induced directional migration. This is the first identification of a role for a Tiam/Rac1 pathway in directional neuronal migration. Among the questions still to be answered are, ''How does BDNF interact with the other growth factors known to regulate migration? Is BDNF secretion polarized in granule cells? How is the gradient of BDNF laid down during development?'' A particularly compelling question is whether the novel mechanism of directional migration reported by Zhou et al. (2007) can be generalized to other migrating stem, precursor, and neuroblast populations. If so, their findings will have established the paradigm that explains a process critical for neuronal development.
